Hormone receptors. An update and application.

Area of Science:

• Oncology
• Endocrinology
• Pathology

Background:

• Hormone receptor status is crucial for determining breast cancer treatment strategies.
• Estrogen receptor (ER) and progesterone receptor (PR) positivity indicates hormone-dependent tumors.
• Endocrine therapy is a key treatment for hormone-sensitive breast cancers.

Purpose of the Study:

• To highlight the significance of measuring hormone receptors in breast cancer specimens.
• To emphasize the role of endocrine therapy in managing ER-positive breast cancers.
• To recommend routine measurement of estrogen and progesterone receptors for all breast cancer patients.

Main Methods:

• Analysis of breast cancer tumor specimens.
• Measurement of estrogen receptors (ER) and progesterone receptors (PR).
• Correlation of ER/PR status with treatment response and recurrence.

Main Results:

• Hormone receptor measurements improve patient selection for targeted therapies.
• Endocrine adjuvant treatment demonstrates efficacy in delaying recurrence for ER-positive breast cancers.
• The effectiveness of endocrine therapy is observed in both pre- and postmenopausal women.

Conclusions:

• Measurement of estrogen and progesterone receptors is a critical diagnostic step.
• Routine testing enables personalized treatment approaches for breast cancer patients.
• Hormone receptor status guides the use of effective endocrine therapies to improve patient outcomes.